21 CFR 213.125
§ 213.125 Labeling issuance.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 213.125, § 213.125 Labeling issuance, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86057
- Permanent ID
ys:prov:86057@1- SHA-256
bcbd255e4098ced4b603be1aaadba90de87f2e761b095b14614b476b2eacff41
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Labeling and packaging operations must be controlled to prevent labeling and product mix-ups. Procedures shall be written and followed describing in sufficient detail the control procedures employed for the issuance of labeling.
(b) Procedures shall be used to reconcile the quantities of labeling issued, used, and returned, and shall require evaluation of discrepancies found between the quantity of medical gas and the quantity of labeling issued when such discrepancies are outside narrow preset limits based on historical operating data. Such discrepancies shall be investigated in accordance with § 213.192. Labeling reconciliation is waived for cut or roll labeling if a 100-percent examination for correct labeling is performed in accordance with § 213.122(f)(2). Labeling reconciliation is also waived for 360° wraparound labels on portable cryogenic medical gas containers.
(c) All excess lot number stickers or decals bearing lot or control numbers shall be discarded.
(d) Bulk or transport containers (as defined in § 201.161(c)(3) of this chapter) are exempt from this section.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.